| Online-Ressource |
Verfasst von: | Altay, Lebriz [VerfasserIn]  |
| Lemke, Julia [VerfasserIn]  |
| Schröder-Braunstein, Jutta [VerfasserIn]  |
| Gietzelt, Caroline [VerfasserIn]  |
| Sitnilska, Vasilena [VerfasserIn]  |
| Schaub, Friederike [VerfasserIn]  |
| Cursiefen, Claus [VerfasserIn]  |
| Enders, Philip [VerfasserIn]  |
| Fauser, Sascha [VerfasserIn]  |
Titel: | Ocular and systemic complement activation during anti-vascular endothelial growth factor treatment and age-related eye disease study 2 dietary supplementation in neovascular age-related macular degeneration |
Verf.angabe: | Lebriz Altay, Julia Lemke, Jutta Schroeder-Braunstein, Caroline Gietzelt, Vasilena Sitnilska, Friederike Schaub, Claus Cursiefen, Philip Enders, Sascha Fauser |
E-Jahr: | 2022 |
Jahr: | JUN 2022 |
Umfang: | 7 S. |
Fussnoten: | Gesehen am 10.11.2022 |
Titel Quelle: | Enthalten in: Ophthalmologica |
Ort Quelle: | Basel : Karger, 1899 |
Jahr Quelle: | 2022 |
Band/Heft Quelle: | 245(2022), 3, Seite 258-264 |
ISSN Quelle: | 1423-0267 |
Abstract: | Purpose: The aim of this study was to investigate the influence of dietary supplementation using Age-Related Eye Disease Study 2 (AREDS2) on complement activation in patients with neovascular age-related macular degeneration (nAMD) under ongoing treatment. Methods: In this prospective, single-center, controlled, open-label investigator-initiated trial, eligible nAMD patients were randomized at a ratio of 1:1 in 2 groups: those with and without dietary AREDS2 supplementation for 4 weeks. Zinc, plasma, and aqueous humor (AH) complement levels were quantified via enzyme-linked immunosorbent assays. Results: Fifty of 62 enrolled patients completed the trial (AREDS2 n = 27, controls n = 23). Systemic zinc and complement levels were not different at baseline between the 2 groups (p > 0.1). At the final visit, systemic zinc levels were significantly higher in the AREDS2 group (10.16 +/- 2.08 mu mol/L; 8.66 +/- 1.17 mu mol/L; p = 0.007), whereas systemic and AH complement levels were not different (p > 0.1). In both groups, no significant change was observed in systemic levels of C3, C3a, FH, FI, and sC5b-9 (p > 0.1). Only systemic complement component Ba showed an increase from baseline to the end visit (p = 0.01). This increase was higher in the control group (p = 0.02) than in the AREDS2 group (p = 0.23). Conclusions: Short-term dietary AREDS2 supplementation leads to a significant increase in systemic zinc levels without any influence on complement activation levels. |
DOI: | doi:10.1159/000516885 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.1159/000516885 |
| Volltext: https://www.karger.com/Article/Abstract/516885 |
| DOI: https://doi.org/10.1159/000516885 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Age-related eye disease study 2 |
| antioxidants |
| association |
| beta-carotene |
| cfh |
| Complement activation |
| drusen |
| genotypes |
| inflammation |
| Neovascular age-related macular degeneration |
| zinc |
| Zinc |
K10plus-PPN: | 1821587677 |
Verknüpfungen: | → Zeitschrift |
Ocular and systemic complement activation during anti-vascular endothelial growth factor treatment and age-related eye disease study 2 dietary supplementation in neovascular age-related macular degeneration / Altay, Lebriz [VerfasserIn]; JUN 2022 (Online-Ressource)